Abingworth LLP PHAT Holdings History
Number of Shares
1.44 Mil
Current Holdings Value*
$16.10 Mil
% of Portfolio
5.25%
Total Estimate Gain
$-37.25 Mil
% of Total Estimate Gain
-74.98%
Abingworth LLP's Phathom Pharmaceuticals Inc Holding Summary
As of 2022-12-31, Abingworth LLP held 1.44 Mil shares of Phathom Pharmaceuticals Inc(PHAT), totaling $16.10 Mil. This investment constitutes 5.25% of their stock portfolio, and Abingworth LLP now holds 3.45% of the outstanding Phathom Pharmaceuticals Inc(PHAT) stock.
The initial trade took place in 2020Q2. And since then Abingworth LLP has made 2 purchases of PHAT, at an average price of $34.61, for a total of 1.44 Mil shares. Based on historical transaction data and PHAT's current price of $8.66, Abingworth LLP's estimated gain on his PHAT holdings is $-37.25 Mil, reflecting a -74.98% gain to date.
Abingworth LLP PHAT ($8.66) Holding Chart
Abingworth LLP PHAT ($8.66) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1